To assess the prognostic impact of CLR expression profiles on DCs, we further examined the hazard ratios of modulated CLRs on DCs combined with some major prognosticators of melanoma progression (such as TNM classification and Breslow depth). The gene discussed is LARS1; the disease is melanoma.